Ken Rose - Providence Business News

Home Tags Ken Rose

TEAM MEETING: From left, Brenton DeBoef, professor of chemistry at the University of Rhode Island, and Alcinous Pharmaceutical team members Nicholas DaSilva, CEO and Ph.D. student in the URI College of Pharmacy; Benjamin Barlock, chief technology officer and Ph.D. student in the URI College of Pharmacy; David Worthen, chief operations officer and URI assistant professor in the Department of Biomedical and Pharmaceutical Sciences and the Department of Chemical Engineering; and Ken Rose, chief scientific officer and Ph.D. student in the URI College of Pharmacy, discuss Alcinous’ latest research project. / PBN PHOTO/RUPERT WHITELEY

Alcinous to use $50K Innovation Voucher to create new PARP inhibitor

Education 12/08/2017

Five weeks prior to celebrating its first year in business, Alcinous Pharmaceuticals received a $50,000 Innovation Voucher from R.I. Commerce Corp. The microcompany had been...

- Featured Event -

Latest News

Barrington home sale topping $3M is town’s 2nd highest of 2026

08/13/2026

CharterCARE Health of Rhode Island selects chief of thoracic surgery

08/13/2026

R.I. awards $1.6M in Learn365RI grants for after-school and summer programs

08/13/2026

Tiverton wealth advisory firm joins California-based AlphaCore

08/13/2026

Former Tallulah’s Taqueria Fox Point property listed for $1.195M

08/13/2026

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.